retatrutide clinical data Triple hormone receptor agonist for metabolic dysfunction-associated steatotic liver disease: a randomized phase 2a trial Retatrutide is one of the

We dont have evidence that giving a healthy human an injectable GLP-1 agonist will directly increase their VO2max or endurance capacity and in fact, what limited human data we have suggests no performance boost

It is also less effective

After 68 weeks, average weight loss in the retatrutide 12 mg group was a remarkable 28.7%, equating to an average weight loss of 71 lbs

Improved Insulin Sensitivity & Glucose Regulation GIP and GLP-1 receptor stimulation enhances glucose-dependent insulin secretion and improves insulin sensitivity

What to expect Midi Custom Rx Midi Custom Rx offers a range of products for skin, hair, and sexual health, prescribed by your Midi clinician, and shipped directly to you from Midis own formulary

If the insurance company requires further clarification or documentation, the approval process can take longer